Paradoxical induction of psoriasis in patients treated with TNFα inhibitors has been attributed to shifts within the balance of TNFα and type I interferons (IFNα) with impact on plasmacytoid dendritic cells (176–181) (Figure 4). This evidence concerns the gene TNF and psoriasis.